Cupid Limited获得欧盟对艾滋病毒和乙型肝炎快速检测的批准,这有利于整个欧洲和全球卫生方案的销售。 Cupid Limited gains EU approval for HIV and Hep B rapid tests, enabling sales across Europe and global health programs.

Cupid有限公司已经为其艾滋病毒1和2和乙型肝炎测试包获得CE(EU IVDR)认证,允许在整个欧洲经济区和其他CE认可的市场上销售。 Cupid Limited has received CE (EU IVDR) certification for its HIV 1&2 and Hepatitis B test kits, allowing sales across the European Economic Area and other CE-recognized markets. 这项批准支持该公司扩大全球传染病诊断范围, 从而得以参与公共卫生计划、政府招标及国际供应链。 The approval supports the company’s expansion in global infectious disease diagnostics, enabling participation in public health programs, government tenders, and international supply chains. 这些快速测试旨在进行早期检测和大规模筛查,符合全球对负担得起的准确诊断的需求。 The rapid tests are designed for early detection and large-scale screening, aligning with global demand for affordable, accurate diagnostics.